NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs051210205

Registered date:25/03/2022

Development of a diagnostic method for pancreatic cancer using 13C glucose

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPancreatic cancer, benign pancreatic diseases, or other gastroenterological cancers
Date of first enrollment30/05/2023
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)Oral administration of 13C-labeled glucose

Outcome(s)

Primary OutcomeLevel of 13C glucose-derived metabolites present in urine after 13C glucose administration
Secondary Outcome1. Presence of 13C glucose-derived metabolites in urine after administration of 13C glucose 2. 13C glucose-derived metabolites (unknown metabolites) 3. Metabolites containing 13C 4. Occurrence of disease or symptom

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 80age old
GenderBoth
Include criteria1. Age over 20, under 80 2. Diagnosed patients of pancreatic cancer, benigh pancreatic disease or other gastroenterological cancer 3. Patients who have given their free and written consent to participate in this clinical research.
Exclude criteria1. ECOG-PS 4, or patients who have difficulty urinating or collecting urine on their own 2. Patients deemed inappropriate by the attending doctor

Related Information

Contact

Public contact
Name Takashi Kobayashi
Address 7-5-2 Kusunoki-cho,Chuo-ku,Kobe,Hyogo Hyogo Japan 650-0017
Telephone +81-78-382-6305
E-mail kobatak@med.kobe-u.ac.jp
Affiliation Kobe University Hospital
Scientific contact
Name Kazutoshi Tobimatsu
Address 7-5-2 Kusunoki-cho,Chuo-ku,Kobe,Hyogo Hyogo Japan 650-0017
Telephone +81-78-382-6305
E-mail tobi@med.kobe-u.ac.jp
Affiliation Kobe University Hospital